RapidX

5 minute point-of-care qPCR tests powered by nanotechnology

Point-of-care testing for bacteria and viruses with extremely short time-to-result (TTR) and multiplexing capabilities of up to 12 targets.

Technology:
  • Antimicrobial stewardship
  • Microbial diagnostics
  • Infection prevention
  • Antimicrobial compound/strategy
  • Removal antibiotics/bacteria

Microorganisms:
  • Bacteria
  • Viruses
  • Fungi
  • Yeasts
  • Parasites

Application:
  • Human
  • Veterinary
  • AgriFood
  • Environmental
  • Other

Development stage:
  • Development
  • Research
  • Validation
  • Market entry
  • Marketed product

Organization:
  • Company
  • Academia
  • Institute
  • NGO
  • Government

Partnering:
  • Co-develop
  • License
  • Outsource
  • Joint Venture
  • Sell

Funding organisation:
  • OTHER / NA
  • CARB-X
  • FIND
  • GARDP
  • REPAIR

Infectious disease area:
  • UTI
  • STI
  • BSI
  • RTI
  • GII
  • SSTI
  • CNSI
  • IAI
  • SSI

Geographic origin:
  • North America
  • South America
  • Eurasia
  • Africa
  • Oceania


We’re looking for clinical partners to access patient samples for trials, or PCR assay/AST genotyping partners to test their assays in our machines.

Our mission is to create 30 minute pathways from symptom to treatment


What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed